Vaccine testing to begin July 27 on 30,000 people

Drug manufacturer Moderna Therapeutics with headquarters in Cambridge, Massachusetts, has announced a clinical trial of a COVID-19 vaccine that will begin on July 27th. 30,000 individuals are enrolled in the test project.